Relmada Therapeutics, Inc. - RLMD
CEO
Director
Chief Executive Officer
Direct Buys
6
$569,827
490,000
Shares
Direct Sells
0
$0
0
Shares
Indirect Buys
0
$0
0
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
05/20/2025
|
05/20/2025 |
Buy
|
147,686 @ $0.56
|
$82,246 | 734,024 (25.19%) | Direct |
|
05/19/2025
|
05/20/2025 |
Buy
|
30,000 @ $0.50
|
$14,994 | 586,338 (5.39%) | Direct |
|
05/16/2025
|
05/20/2025 |
Buy
|
172,314 @ $0.45
|
$77,472 | 556,338 (44.87%) | Direct |
|
09/11/2024
|
09/11/2024 |
Buy
|
51,407 @ $2.99
|
$153,707 | 384,024 (15.46%) | Direct |
|
09/10/2024
|
09/11/2024 |
Buy
|
33,014 @ $2.75
|
$90,788 | 332,617 (11.02%) | Direct |
|
09/09/2024
|
09/11/2024 |
Buy
|
55,579 @ $2.71
|
$150,619 | 299,603 (22.78%) | Direct |